Therefore, the study hypothesizes that mutations of lipid-related EHBP1 SNPs may result in different lipid phenotypes and these SNPs might interact with the environment to alter dyslipidemia risk; moreover, they might interact with PCSK9 to affect lipid levels. The gene discussed is EHBP1; the disease is metabolic syndrome.